767 related articles for article (PubMed ID: 12074830)
1. The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet's disease.
Orem A; Yandi YE; Vanizor B; Cimşit G; Uydu HA; Malkoç M
Clin Biochem; 2002 May; 35(3):217-24. PubMed ID: 12074830
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis.
Vanizor Kural B; Orem A; Cimşit G; Yandi YE; Calapoglu M
Clin Chim Acta; 2003 Feb; 328(1-2):71-82. PubMed ID: 12559600
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against oxidatively modified low-density lipoprotein in patients with Behçet's disease.
Orem A; Cimşit G; Değer O; Vanizor B; Karahan SC
Dermatology; 1999; 198(3):243-6. PubMed ID: 10393445
[TBL] [Abstract][Full Text] [Related]
4. The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status.
Orem C; Orem A; Uydu HA; Celik S; Erdöl C; Kural BV
Coron Artery Dis; 2002 Feb; 13(1):65-71. PubMed ID: 11917201
[TBL] [Abstract][Full Text] [Related]
5. The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis.
Orem A; Cimşit G; Değer O; Orem C; Vanizor B
Clin Chim Acta; 1999 Jun; 284(1):81-8. PubMed ID: 10437645
[TBL] [Abstract][Full Text] [Related]
6. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
[TBL] [Abstract][Full Text] [Related]
7. The effects of lipid-lowering therapy on paraoxonase activities and their relationships with the oxidant-antioxidant system in patients with dyslipidemia.
Kural BV; Orem C; Uydu HA; Alver A; Orem A
Coron Artery Dis; 2004 Aug; 15(5):277-83. PubMed ID: 15238825
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.
Buldanlioglu S; Turkmen S; Ayabakan HB; Yenice N; Vardar M; Dogan S; Mercan E
Br J Dermatol; 2005 Sep; 153(3):526-30. PubMed ID: 16120137
[TBL] [Abstract][Full Text] [Related]
9. Age-related modification of antioxidant enzyme activities in relation to cardiovascular risk factors.
Fabian E; Bogner M; Elmadfa I
Eur J Clin Invest; 2012 Jan; 42(1):42-8. PubMed ID: 21722101
[TBL] [Abstract][Full Text] [Related]
10. Cameroonian professional soccer players and risk of atherosclerosis.
Nansseu JR; Ama Moor VJ; Takam RDM; Zing-Awona B; Azabji-Kenfack M; Tankeu F; Tchoula CM; Moukette BM; Ngogang JY
BMC Res Notes; 2017 Jun; 10(1):186. PubMed ID: 28577561
[TBL] [Abstract][Full Text] [Related]
11. Oxidant/antioxidant status in men with Behçet's disease.
Taysi S; Demircan B; Akdeniz N; Atasoy M; Sari RA
Clin Rheumatol; 2007 Mar; 26(3):418-22. PubMed ID: 17206395
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of dietary copper supplementation on serum lipids and antioxidant defenses in rats.
Galhardi CM; Diniz YS; Rodrigues HG; Faine LA; Burneiko RC; Ribas BO; Novelli EL
Ann Nutr Metab; 2005; 49(5):283-8. PubMed ID: 16088091
[TBL] [Abstract][Full Text] [Related]
13. [Oxidized LDL and lipids as risk factors for ischemic heart disease in type 2 diabetes].
Zamaklar M; Lalić K; Rajković N; Trifunović D; Dragasević M; Popović L; Drasković D; Laić N; Jotić A; Vasović O; Lukić L; Milicić T; Potpara T
Vojnosanit Pregl; 2005; 62(7-8):529-36. PubMed ID: 16171015
[TBL] [Abstract][Full Text] [Related]
14. Oxidant/antioxidant status, lipids and hormonal profile in overweight women with breast cancer.
Badid N; Ahmed FZ; Merzouk H; Belbraouet S; Mokhtari N; Merzouk SA; Benhabib R; Hamzaoui D; Narce M
Pathol Oncol Res; 2010 Jun; 16(2):159-67. PubMed ID: 19731090
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of autoantibodies against oxidized LDL (oLAB) and blood antioxidant status in professional soccer players.
Kłapcińska B; Kempa K; Sobczak A; Sadowska-Krepa E; Jagsz S; Szołtysek I
Int J Sports Med; 2005; 26(1):71-8. PubMed ID: 15643538
[TBL] [Abstract][Full Text] [Related]
16. Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients.
Vanizor Kural B; Orem A; Cimşit G; Uydu HA; Yandi YE; Alver A
Clin Chim Acta; 2003 Jun; 332(1-2):23-30. PubMed ID: 12763276
[TBL] [Abstract][Full Text] [Related]
17. Decreased neutrophil antioxidative enzyme activities and increased lipid peroxidation in hyperlipoproteinemic human subjects.
Efe H; Değer O; Kirci D; Karahan SC; Orem A; Calapoğlu M
Clin Chim Acta; 1999 Jan; 279(1-2):155-65. PubMed ID: 10064127
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against oxidized LDL and serum total antioxidant status in active cyclists and ex-cyclists.
García-Unzueta MT; Gutiérrez-Sánchez JB; de Mier I; Amado JA; Berrazueta JR
Horm Metab Res; 2003 Sep; 35(9):541-5. PubMed ID: 14517771
[TBL] [Abstract][Full Text] [Related]
19. Lipid peroxidation and erythrocyte antioxidant enzymes in patients with Behçet's disease.
Köse K; Yazici C; Cambay N; Aşcioğlu O; Doğan P
Tohoku J Exp Med; 2002 May; 197(1):9-16. PubMed ID: 12180795
[TBL] [Abstract][Full Text] [Related]
20. [The effect of statins on lipids peroxidation and activities of antioxidants enzymes in patients with dyslipidemia].
Broncel M; Koter-Michalak M; Chojnowska-Jezierska J
Przegl Lek; 2006; 63(9):738-42. PubMed ID: 17479860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
